Skip to main content

Commit To Purchase Neurogene At $25, Earn 16% Using Options

Investors eyeing a purchase of Neurogene Inc (NGNE) shares, but cautious about paying the going market price of $40.53/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2027 put at the $25 strike, which has a bid at the time of this writing of $4.00..
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.